Literature DB >> 11193159

Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death.

T Arendt1, M Holzer, A Stöbe, U Gärtner, H J Lüth, M K Brückner, U Ueberham.   

Abstract

Neurodegeneration in Alzheimer's disease (AD) is associated with the appearance of dystrophic neuronal growth profiles that most likely reflect an impairment of neuronal reorganization. This process of morphodysregulation, which eventually goes awry and becomes a disease itself, might be triggered either by a variety of life events that place an additional burden on the plastic capability of the brain or by genetic pertubations that shift the threshold for decompensation. This paper summarizes recent evidence that impairment of the p21ras intracellular signal transduction, which is is mediated by a hierarchy of phosphorylation signals and eventually results in loss of differentiation control and an attempt of neurons to re-enter the cell-cycle, is critically involved in this process. Neurodegeneration might thus be viewed as an alternative effector pathway of those events that in the dividing cell would lead to cellular transformation. This hypothesis might be of heuristic value for the development of a therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193159     DOI: 10.1111/j.1749-6632.2000.tb06931.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  27 in total

1.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  An orderly retreat: Dedifferentiation is a regulated process.

Authors:  Mariko Katoh; Chad Shaw; Qikai Xu; Nancy Van Driessche; Takahiro Morio; Hidekazu Kuwayama; Shinji Obara; Hideko Urushihara; Yoshimasa Tanaka; Gad Shaulsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-21       Impact factor: 11.205

3.  Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model.

Authors:  Gauri H Malthankar-Phatak; Yin-Guo Lin; Nicholas Giovannone; Robert Siman
Journal:  Aging Dis       Date:  2011-07-28       Impact factor: 6.745

Review 4.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

5.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.

Authors:  Eric M Blalock; Heather M Buechel; Jelena Popovic; James W Geddes; Philip W Landfield
Journal:  J Chem Neuroanat       Date:  2011-07-02       Impact factor: 3.052

6.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

Review 7.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

Review 8.  Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.

Authors:  Chinthalapally V Rao; Mudassir Farooqui; Adam S Asch; Hiroshi Y Yamada
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

Review 9.  Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2005-01       Impact factor: 1.990

10.  Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products.

Authors:  A Schmidt; B Kuhla; K Bigl; G Münch; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.